Literature DB >> 32175404

Comparison of four lymph node staging systems for predicting prognosis for stage IV rectum cancer.

Lingyu Han1,2, Shaobo Mo1,2, Wenqiang Xiang1,2, Qingguo Li1,2, Renjie Wang1,2, Ye Xu1,2, Weixing Dai1,2, Guoxiang Cai1,2.   

Abstract

BACKGROUND: With recommendation of surgical management in primary site, both the positive and negative lymph nodes (LNs) retrieved have been emphasized to predict prognosis in stage IV rectum cancer. Therefore, we attempt to compare the prognostic performance of American Joint Committee on Cancer (AJCC) N-stage relative to lymph node ratio (LNR), log odds of metastatic lymph nodes (LODDS), and N-score in stage IV rectal cancer.
METHODS: Total 5,090 patients taken surgical resection of primary site in rectum cancer with distant metastasis were extracted from Surveillance, Epidemiology, and End Results Program (SEER) database. Harrell's C statistic (C-index) and Akaike's Information Criterion (AIC) were used to evaluate the discriminative ability of the different LN staging systems.
RESULTS: Of the 3,243 patients without radiotherapy, 82.46% (n=2,675) had been found with lymph nodes metastasis with median number of 16 lymph nodes collected (IQR: 11-22). Modeled as categorical cutoff variables for further clinical usage, when number of LNs was between 12 and 25 (C-index: 0.5997, AIC: 1,698.015), 8th AJCC N-stage outperformed other three schemas with increasing C-index and less AIC value. Assessed as continuous values, the LODDS shown as the best schemas with greatest discriminatory power (C-index: 0.5971, AIC: 3,680.017), generally. On the other hand, in the cohorts of other 1274 patients taken radiation, the median number of lymph nodes retrieved was 13 (IQR: 9-18). LODDS still remained remarkable performance as continuous (C-index: 0.5912; AIC: 1,058.765) and categorical variables (C-index: 0.5700; AIC: 1,061.703), while N-staging outperformed with less than 25 lymph nodes retrieved (LNs <12 C-index: 0.5678, AIC: 481.94; 12< LNs <25 C-index: 0.5933, AIC: 390.395).
CONCLUSIONS: When assessed as categorical variables, N-stage performed superiorly with adequate lymph nodes examined, whether the patients have got radiotherapy prior to surgery or not. LODDS showed, when assessed as a continuous variable, good discriminative ability and goodness of fit in predicting survival for stage IV rectum cancer patients regardless of radiation therapy status. 2020 Annals of Translational Medicine. All rights reserved.

Entities:  

Keywords:  Colorectal cancer; lymph nodes (LNs); prognostic factor; survival analysis

Year:  2020        PMID: 32175404      PMCID: PMC7049057          DOI: 10.21037/atm.2019.12.90

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN: 2305-5839


  20 in total

1.  Number of lymph nodes retrieved is an important determinant of survival of patients with stage II and stage III colorectal cancer.

Authors:  Kenjiro Kotake; Satoshi Honjo; Kenichi Sugihara; Yojiro Hashiguchi; Tomoyuki Kato; Susumu Kodaira; Tetsuichiro Muto; Yasuo Koyama
Journal:  Jpn J Clin Oncol       Date:  2011-11-18       Impact factor: 3.019

2.  Clinical benefit of surgery for stage IV colorectal cancer with synchronous peritoneal metastasis.

Authors:  Hirotoshi Kobayashi; Kenjiro Kotake; Kimihiko Funahashi; Kazuo Hase; Koichi Hirata; Tsuneo Iiai; Shingo Kameoka; Yukihide Kanemitsu; Koutarou Maeda; Akihiko Murata; Masayuki Ohue; Kazuo Shirouzu; Keiichi Takahashi; Toshiaki Watanabe; Hideaki Yano; Toshimasa Yatsuoka; Yojiro Hashiguchi; Kenichi Sugihara
Journal:  J Gastroenterol       Date:  2013-06-24       Impact factor: 7.527

3.  Predictive Nomograms for Synchronous Distant Metastasis in Rectal Cancer.

Authors:  Apostolos Gaitanidis; Michail Alevizakos; Alexandra Tsaroucha; Christos Tsalikidis; Michail Pitiakoudis
Journal:  J Gastrointest Surg       Date:  2018-04-16       Impact factor: 3.452

4.  Colon cancer survival is associated with decreasing ratio of metastatic to examined lymph nodes.

Authors:  Adam C Berger; Elin R Sigurdson; Thomas LeVoyer; Alexandra Hanlon; Robert J Mayer; John S Macdonald; Paul J Catalano; Daniel G Haller
Journal:  J Clin Oncol       Date:  2005-12-01       Impact factor: 44.544

Review 5.  ACR Appropriateness Criteria® rectal cancer: metastatic disease at presentation.

Authors:  Karyn A Goodman; Sarah A Milgrom; Joseph M Herman; May Abdel-Wahab; Nilofer Azad; A William Blackstock; Prajnan Das; Theodore S Hong; Salma K Jabbour; William E Jones; Andre A Konski; Albert C Koong; Rachit Kumar; Miguel Rodriguez-Bigas; William Small; Charles R Thomas; W Warren Suh
Journal:  Oncology (Williston Park)       Date:  2014-10       Impact factor: 2.990

6.  Comparison of three lymph node classifications for survival prediction in distant metastatic gastric cancer.

Authors:  Rui Zhou; Jingwen Zhang; Huiying Sun; Yulin Liao; Wangjun Liao
Journal:  Int J Surg       Date:  2016-10-03       Impact factor: 6.071

7.  Primary Tumor Resection for Stage IV Colorectal Cancer in the Era of Targeted Chemotherapy.

Authors:  Dai Shida; Narikazu Boku; Taro Tanabe; Takefumi Yoshida; Shunsuke Tsukamoto; Atsuo Takashima; Yukihide Kanemitsu
Journal:  J Gastrointest Surg       Date:  2018-11-27       Impact factor: 3.452

8.  Rectal outcomes after a liver-first treatment of patients with stage IV rectal cancer.

Authors:  Nicolas C Buchs; Frédéric Ris; Pietro E Majno; Axel Andres; Wulfran Cacheux; Pascal Gervaz; Arnaud D Roth; Sylvain Terraz; Laura Rubbia-Brandt; Philippe Morel; Gilles Mentha; Christian Toso
Journal:  Ann Surg Oncol       Date:  2014-09-09       Impact factor: 5.344

9.  Protocol for the examination of specimens from patients with primary carcinoma of the colon and rectum.

Authors:  Mary Kay Washington; Jordan Berlin; Philip Branton; Lawrence J Burgart; David K Carter; Patrick L Fitzgibbons; Kevin Halling; Wendy Frankel; John Jessup; Sanjay Kakar; Bruce Minsky; Raouf Nakhleh; Carolyn C Compton
Journal:  Arch Pathol Lab Med       Date:  2009-10       Impact factor: 5.534

Review 10.  Challenges in the multidisciplinary management of stage IV colon and rectal cancer.

Authors:  Pompiliu Piso; Dirk Arnold; Gabriel Glockzin
Journal:  Expert Rev Gastroenterol Hepatol       Date:  2014-09-05       Impact factor: 3.869

View more
  6 in total

1.  A novel prognostic nomogram for patients with surgically resected perihilar cholangiocarcinoma: a SEER-based study.

Authors:  Pengfei Li; Lujun Song
Journal:  Ann Transl Med       Date:  2021-01

2.  Comprehensive analysis of lymph nodes metastasis associated genes in cervical cancer and its significance in treatment and prognosis.

Authors:  Ping Yang; Youqin Ruan; Zhiling Yan; Yang Gao; Hongying Yang; Shaojia Wang
Journal:  BMC Cancer       Date:  2021-11-16       Impact factor: 4.430

3.  Prognostic Nomogram for Rectal Cancer Patients With Tumor Deposits.

Authors:  Xiaohong Zhong; Lei Wang; Lingdong Shao; Xueqing Zhang; Liang Hong; Gang Chen; Junxin Wu
Journal:  Front Oncol       Date:  2022-02-02       Impact factor: 6.244

4.  Combination of Changes in CEA and CA199 Concentration After Neoadjuvant Chemoradiotherapy Could Predict the Prognosis of Stage II/III Rectal Cancer Patients Receiving Neoadjuvant Chemoradiotherapy Followed by Total Mesorectal Excision.

Authors:  Jieyi Zhao; Huamin Zhao; Tingting Jia; Shiru Yang; Xiaoyu Wang
Journal:  Cancer Manag Res       Date:  2022-09-29       Impact factor: 3.602

5.  Prognostic Evaluation for Patients over 45 Years Old with Gallbladder Adenocarcinoma Resection: A SEER-Based Nomogram Analysis.

Authors:  Pengfei Li; Lujun Song
Journal:  Biomed Res Int       Date:  2020-07-18       Impact factor: 3.411

6.  The prognostic performance of the log odds of positive lymph nodes in patients with esophageal squamous cell carcinoma: A population study of the US SEER database and a Chinese single-institution cohort.

Authors:  Hongdian Zhang; Wanyi Xiao; Peng Ren; Kai Zhu; Ran Jia; Yueyang Yang; Lei Gong; Zhentao Yu; Peng Tang
Journal:  Cancer Med       Date:  2021-07-09       Impact factor: 4.452

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.